Department of Anaesthesiology and Intensive Care, Institute of Oncology, Ljubljana 1000, Slovenia.
J Clin Anesth. 2011 Feb;23(1):42-6. doi: 10.1016/j.jclinane.2010.06.007.
To evaluate retrospectively serum albumin concentrations as well as morbidity and mortality of abdominal surgical patients who--if hypoalbuminemic--did not receive human albumin solutions versus those who did receive such solutions.
Retrospective observational study.
Academic community hospital.
The records of 76 consecutive patients who had undergone elective abdominal surgery were reviewed. Preoperative and postoperative serum albumin concentrations up to the seventh day after surgery were recorded. Morbidity and mortality were followed until the time of discharge from the hospital.
38 patients who received albumin replacement if they were hypoalbuminemic versus 38 patients who did not receive albumin replacement showed no significant difference in cumulative (P < 0.52) or individual postoperative complications (infections P < 0.35, cardiovascular complications P < 1.0, organ failure P < 0.67, thromboembolic incidents P < 0.26), and mortality (P < 0.47).
Postoperative serum albumin concentration had no correlation with postoperative morbidity. There is no justification for perioperative albumin replacement in abdominal cancer surgical patients.
回顾性评估血清白蛋白浓度以及接受或未接受人血白蛋白溶液治疗的腹部外科手术患者的发病率和死亡率。
回顾性观察性研究。
学术社区医院。
回顾分析了 76 例连续接受择期腹部手术的患者的记录。记录了手术前和手术后直至术后第 7 天的血清白蛋白浓度。随访发病率和死亡率,直至患者出院。
接受白蛋白替代治疗的 38 例低白蛋白血症患者与未接受白蛋白替代治疗的 38 例患者在累积(P < 0.52)或单个术后并发症(感染 P < 0.35,心血管并发症 P < 1.0,器官衰竭 P < 0.67,血栓栓塞事件 P < 0.26)和死亡率(P < 0.47)方面无显著差异。
术后血清白蛋白浓度与术后发病率无关。围手术期白蛋白替代治疗在腹部癌症手术患者中没有依据。